mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |